https://markets.businessinsider.com/news/stocks/illumina-ilmn-receives-a-hold-from-canaccord-genuity-1035796887
Illumina (ILMN) Receives a Hold from Canaccord Genuity | Markets Insider
In a report released today, Kyle Mikson CFA from Canaccord Genuity maintained a Hold rating on Illumina, with a price target of $150.00.Claim 50...
canaccord genuityilluminailmnreceiveshold
https://www.benzinga.com/analyst-ratings/23/04/32016590/baird-maintains-neutral-rating-for-illumina-heres-what-you-need-to-know
Baird Maintains Neutral Rating for Illumina: Here's What You Need To Know - Illumina (NASDAQ:ILMN)...
what you need to know
https://markets.businessinsider.com/news/stocks/barclays-keeps-their-sell-rating-on-illumina-ilmn-1036021128
Barclays Keeps Their Sell Rating on Illumina (ILMN) | Markets Insider
In a report released today, Luke Sergott from Barclays maintained a Sell rating on Illumina, with a price target of $110.00.Claim 30% Off TipRan...
barclayskeepssellratingillumina
https://markets.businessinsider.com/news/stocks/bank-of-america-securities-reaffirms-their-sell-rating-on-illumina-ilmn-1035887463
Bank of America Securities Reaffirms Their Sell Rating on Illumina (ILMN) | Markets Insider
In a report released today, Michael Ryskin from Bank of America Securities maintained a Sell rating on Illumina, with a price target of $85.00.C...
bank of america
https://omicsomics.blogspot.com/2019/07/uk-cma-ilmnpacb-inconvenience-of-being.html
Omics! Omics!: UK CMA & ILMN/PACB: The Inconvenience of Being Earnest.
As part two of a yet-to-be-determined number of pieces on the UK's CMA preliminary analysis of the proposed Pacific Biosciences acquisition ...
omicsukcmailmnpacb